Literature DB >> 13783405

Medical management of ulcerative colitis.

G WATKINSON.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES/therapy; COLITIS, ULCERATIVE/therapy; CORTICOTROPIN/therapy; SULFONAMIDES/therapy

Mesh：

Substances：

Year:  1961        PMID： 13783405      PMCID： PMC1952956          DOI： 10.1136/bmj.1.5220.147

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  Cancer in ulcerative colitis.

Authors:  G SLANEY; B N BROOKE
Journal:  Lancet       Date:  1959-10-31       Impact factor: 79.321

2.  Right-sided or segmental ulcerative colitis.

Authors:  G WATKINSON; H THOMPSON; J C GOLIGHER
Journal:  Br J Surg       Date:  1960-01       Impact factor: 6.939

3.  Ulcerative colitis and carcinoma coli.

Authors:  H ROSENQVIST; H OHRLING; R LAGERCRANTZ; N EDLING
Journal:  Lancet       Date:  1959-05-02       Impact factor: 79.321

4.  Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis.

Authors:  G WATKINSON
Journal:  Br Med J       Date:  1958-11-01

5.  Corticotropin (ACTH) and the adrenal steroids in the management of ulcerative colitis: observations in 240 patients.

Authors:  J B KIRSNER; W L PALMER; J A SPENCER; R O BICKS; C F JOHNSON
Journal:  Ann Intern Med       Date:  1959-04       Impact factor: 25.391

6.  The role of ACTH and adrenal steroids in perforation of the colon in ulcerative colitis; a clinical-pathologic study.

Authors:  M B GOLDGRABER; J B KIRSNER; W L PALMER
Journal:  Gastroenterology       Date:  1957-09       Impact factor: 22.682

7.  The use of ACTH and cortisone in idiopathic ulcerative colitis.

Authors:  E J MALTBY; R C DICKSON; P M O'SULLIVAN
Journal:  Can Med Assoc J       Date:  1956-01-01       Impact factor: 8.262

8.  The treatment of ulcerative colitis.

Authors:  N SVARTZ
Journal:  Gastroenterologia       Date:  1956

9.  Response of ulcerative colitis to therapy with salicylazosulfapyridine.

Authors:  L M MORRISON
Journal:  J Am Med Assoc       Date:  1953-01-31
  9 in total
  6 in total

1.  The management of fulminant ulcerative colitis.

Authors:  N D GALLAGHER; S J GOULSTON; N WYNDHAM; W MORROW
Journal:  Gut       Date:  1962-12       Impact factor: 23.059

2.  Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.

Authors:  E M Cooke
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

Review 3.  The medical treatment of ulcerative colitis.

Authors:  G Watkinson
Journal:  Postgrad Med J       Date:  1968-09       Impact factor: 2.401

4.  Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.

Authors:  H Schröder; D A Evans
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

5.  Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

Authors:  S A Riley; V Mani; M J Goodman; M E Herd; S Dutt; L A Turnberg
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

Review 6.  Sulphasalazine: a review of 40 years' experience.

Authors:  G Watkinson
Journal:  Drugs       Date:  1986       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.